Facility Inspections Factor in Slow Generics Reviews, Says GAO

Drug GMP Report
A A
The FDA is improving its response times for generic drug applications, but facility inspections remain a major hang-up in the process, according to a GAO report.

To View This Article:

Login

Subscribe To Drug GMP Report